Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Beck

Showing results (31-40 of 116) with videos related to

Pageof 12
Sort By:
Theriogenology|November 6, 2012
Early pregnancy diagnosis in dairy cows using circulating nucleic acidsJennifer Mayer, Jan T Soller, Julia Beck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 27, 2024
Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical ImplicationsAylin Akifova, Klemens Budde, Michael Oellerich, et al.
Plos One|June 10, 2016
Correction: The Holstein Friesian Lethal Haplotype 5 (HH5) Results from a Complete Deletion of TBF1M and Cholesterol Deficiency (CDH) from an ERV-(LTR) Insertion into the Coding Region of APOBEkkehard Schütz, Christin Wehrhahn, Marius Wanjek, et al.
Journal of Clinical Medicine|March 29, 2023
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot StudyBilgin Osmanodja, Aylin Akifova, Michael Oellerich, et al.
Scientific Reports|June 23, 2016
Genomic amplification of the caprine EDNRA locus might lead to a dose dependent loss of pigmentationFiona Menzi, Irene Keller, Irene Reber, et al.
Therapeutic Drug Monitoring|September 21, 2022
Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal TransplantationMichael Oellerich, Klemens Budde, Bilgin Osmanodja, et al.
Investigational New Drugs|November 10, 2017
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J Weiss, Lisa Blaydorn, Julia Beck, et al.
Investigational New Drugs|April 26, 2019
Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J Weiss, Lisa Blaydorn, Julia Beck, et al.
The Journal of Molecular Diagnostics : JMD|March 16, 2010
Serum DNA motifs predict disease and clinical status in multiple sclerosisJulia Beck, Howard B Urnovitz, Marina Saresella, et al.
Frontiers in Genetics|November 7, 2022
Donor-derived cell-free DNA as a diagnostic tool in transplantationMichael Oellerich, Klemens Budde, Bilgin Osmanodja, et al.
Pageof 12

Showing results (31-40 of 116) with videos related to

Sort By:
Pageof 12
Theriogenology|November 6, 2012
Early pregnancy diagnosis in dairy cows using circulating nucleic acidsJennifer Mayer, Jan T Soller, Julia Beck, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|August 27, 2024
Perspective for Donor-Derived Cell-Free DNA in Antibody-Mediated Rejection After Kidney Transplantation: Defining Context of Use and Clinical ImplicationsAylin Akifova, Klemens Budde, Michael Oellerich, et al.
Plos One|June 10, 2016
Correction: The Holstein Friesian Lethal Haplotype 5 (HH5) Results from a Complete Deletion of TBF1M and Cholesterol Deficiency (CDH) from an ERV-(LTR) Insertion into the Coding Region of APOBEkkehard Schütz, Christin Wehrhahn, Marius Wanjek, et al.
Journal of Clinical Medicine|March 29, 2023
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot StudyBilgin Osmanodja, Aylin Akifova, Michael Oellerich, et al.
Scientific Reports|June 23, 2016
Genomic amplification of the caprine EDNRA locus might lead to a dose dependent loss of pigmentationFiona Menzi, Irene Keller, Irene Reber, et al.
Therapeutic Drug Monitoring|September 21, 2022
Donor-Derived Cell-free DNA for Personalized Immunosuppression in Renal TransplantationMichael Oellerich, Klemens Budde, Bilgin Osmanodja, et al.
Investigational New Drugs|November 10, 2017
Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J Weiss, Lisa Blaydorn, Julia Beck, et al.
Investigational New Drugs|April 26, 2019
Correction to: Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinomaGlen J Weiss, Lisa Blaydorn, Julia Beck, et al.
The Journal of Molecular Diagnostics : JMD|March 16, 2010
Serum DNA motifs predict disease and clinical status in multiple sclerosisJulia Beck, Howard B Urnovitz, Marina Saresella, et al.
Frontiers in Genetics|November 7, 2022
Donor-derived cell-free DNA as a diagnostic tool in transplantationMichael Oellerich, Klemens Budde, Bilgin Osmanodja, et al.
Pageof 12